Lesnar, 39, tested positive for clomiphene and its
metabolite, 4-hydroxyclomiphene, following an out-of-competition
urine test on June 28 last year and an in-competition urine test
on July 9 at UFC 200 in Las Vegas, USADA said in a press
release.
Clomiphene is an anti-estrogen agent that can indirectly raise
natural testosterone levels in the body, and can also counter
the side-effects of anabolic steroid use.
The suspension started on July 15, six days after the
American-born Canadian resident competed in UFC (Ultimate
Fighting Championship) 200, beating Mark Hunt by unanimous
decision in his first appearance in the octagon since December
2011.
Lesnar was a noted professional wrestler before switching to
UFC, where he quickly found success.
(Corrects Lesnar country of birth in para 4)
(Reporting by Andrew Both in Cary, North Carolina, editing by
Neil Robisnon)
[© 2017 Thomson Reuters. All rights
reserved.] Copyright 2017 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
|
|